// App-Quantinova.ai

2798 : Safety and Efficacy of CD19 CAR T-Cells for Pediatric Relapsed Acute Lymphoblastic Leukemia with Active CNS Involvement

Researchers

Presenter

  • Elad Jacoby

Principal Investigators

  • Sara Ghorashian

  • Britta Julia Vormoor

  • Barbara De Moerloose

  • Nicole Bodmer

  • Michael Maschan

  • Asaf David Yanir

  • Bella Bielorai

  • Srdan Rogosic

  • Olga Molostova

  • Claudia Rossig

  • Amos Toren

  • Arend von Stackelberg

  • Jean-Pierre Bourquin

Medical Centers

  • Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat-Gan, Israel

  • Sackler Faculty Of Medicine, Tel-Aviv University, Tel-Aviv, Israel

  • Nephrology Unit, Developmental Biology and Cancer Program, UCL Great Ormond Street Institute of Child Health, London, United Kingdom

  • Princess Maxima Center for Pediatric Oncology, Netherlands

  • Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium

  • University Childrens Hospital, Zurich, Switzerland

  • Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation

  • Schneider Childrens Medical Center, Petah Tikva, Israel

  • Division of Pediatric Hematology and Oncology, Sheba Medical Center, Ramat-Gan, ISR

  • Great Ormond Street Institute of Child Health, UCL, London, United Kingdom

  • Pediatric Hematology and Oncology, University Hospital, Muenster, Germany

  • Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat-Gan, Israel

  • Department of Pediatric Oncology/Hematology, Charite Medical University Berlin, Berlin, Germany.

  • Universitaets-Kinderspital Zurich, Zurich, Switzerland

Locations

  • Israel

  • United Kingdom

  • Netherlands

  • Belgium

  • Switzerland

  • Russia

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 19

  • Coxsackie Virus And Adenovirus Receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved